 The purpose of this study is to evaluate the safety and tolerability of an HIV-1 neftatvif, env pDNA vaccine delivered with electroporation EP, followed by a recombinant vesicular stomatitis virus rVSV HIV envC vaccine boost, in healthy, HIV-uninfected adults. 